• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution.在药房配制的血液滤过溶液中硫酸镁和碳酸氢钠的物理相容性。
Am J Health Syst Pharm. 2010 Apr 1;67(7):562-5. doi: 10.2146/ajhp090342.
2
Stability of sodium bicarbonate solutions in polyolefin bags.碳酸氢钠溶液在聚烯烃袋中的稳定性。
Am J Health Syst Pharm. 2010 Jun 15;67(12):1026-9. doi: 10.2146/ajhp090301.
3
Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin bags.冷冻、长期储存及微波解冻对双氯芬酸与碳酸氢钠在5%葡萄糖聚烯烃袋中的混合物稳定性的影响
Ann Pharm Fr. 2009 Nov;67(6):427-32. doi: 10.1016/j.pharma.2009.09.004. Epub 2009 Oct 24.
4
The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure.急性肾衰竭危重症患者持续血液滤过期间不同缓冲液的应用。
Intensive Care Med. 1999 Nov;25(11):1244-51. doi: 10.1007/s001340051052.
5
Compatibility of linezolid with commercial peritoneal dialysis solutions.利奈唑胺与市售腹膜透析液的相容性。
Am J Health Syst Pharm. 2018 Oct 1;75(19):1467-1477. doi: 10.2146/ajhp170318.
6
Stability studies of two compounded solutions potentially used in tumor lysis syndrome.两种可能用于肿瘤溶解综合征的复合溶液的稳定性研究。
J Oncol Pharm Pract. 2019 Sep;25(6):1434-1438. doi: 10.1177/1078155219840421. Epub 2019 Apr 2.
7
Physical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injection.两性霉素B与硫酸镁在5%葡萄糖注射液中的物理相容性和化学稳定性。
DICP. 1991 Feb;25(2):123-6. doi: 10.1177/106002809102500202.
8
Effect of procaine on the pH of buffered and unbuffered cardioplegic solutions.普鲁卡因对缓冲和未缓冲心脏停搏液pH值的影响。
Am J Hosp Pharm. 1986 Sep;43(9):2213-8.
9
Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation.小儿对流血液滤过:正常碳酸氢盐置换液与枸橼酸盐抗凝
Am J Kidney Dis. 2003 Dec;42(6):1248-52. doi: 10.1053/j.ajkd.2003.08.026.
10
The acid-base effects of continuous hemofiltration with lactate or bicarbonate buffered replacement fluids.使用乳酸盐或碳酸氢盐缓冲置换液进行持续血液滤过的酸碱效应。
Int J Artif Organs. 2003 Jun;26(6):477-83. doi: 10.1177/039139880302600605.

本文引用的文献

1
Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C.在37摄氏度模拟输注条件下含有机钙和无机磷酸盐的新生儿全胃肠外营养混合液的物理相容性
Pediatr Crit Care Med. 2009 Mar;10(2):213-6. doi: 10.1097/PCC.0b013e31819a3bf4.
2
Medication errors and patient complications with continuous renal replacement therapy.持续肾脏替代治疗中的用药错误与患者并发症
Pediatr Nephrol. 2006 Jun;21(6):842-5. doi: 10.1007/s00467-006-0049-y. Epub 2006 Apr 19.
3
Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts.含有机钙和无机磷酸盐的新生儿全胃肠外营养混合液的物理相容性
Am J Health Syst Pharm. 2005 Jun 1;62(11):1177-83. doi: 10.1093/ajhp/62.11.1177.
4
Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards.全胃肠外营养混合液的稳定性和相容性评估技术:依据药典标准设定标杆
Curr Opin Clin Nutr Metab Care. 2005 May;8(3):297-303. doi: 10.1097/01.mco.0000165009.24202.64.
5
Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation.小儿对流血液滤过:正常碳酸氢盐置换液与枸橼酸盐抗凝
Am J Kidney Dis. 2003 Dec;42(6):1248-52. doi: 10.1053/j.ajkd.2003.08.026.
6
The first international consensus conference on continuous renal replacement therapy.首届连续性肾脏替代治疗国际共识会议。
Kidney Int. 2002 Nov;62(5):1855-63. doi: 10.1046/j.1523-1755.2002.00613.x.
7
Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.碳酸氢盐缓冲液和乳酸盐缓冲液替代液对连续性静脉-静脉血液滤过(CVVH)患者心血管结局的影响。
Kidney Int. 2000 Oct;58(4):1751-7. doi: 10.1046/j.1523-1755.2000.00336.x.
8
Continuous renal replacement therapies: an update.
Am J Kidney Dis. 1998 Aug;32(2):185-207. doi: 10.1053/ajkd.1998.v32.pm9708602.
9
Continuous venovenous hemofiltration in acute renal failure: is a bicarbonate- or lactate-buffered substitution better?
Contrib Nephrol. 1995;116:38-47. doi: 10.1159/000424611.
10
Bicarbonate buffer for CAPD solution.
Trans Am Soc Artif Intern Organs. 1985;31:668-72.

在药房配制的血液滤过溶液中硫酸镁和碳酸氢钠的物理相容性。

Physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution.

机构信息

Pharmacy Department, National Institutes of Health (NIH), Bethesda, MD 20892, USA.

出版信息

Am J Health Syst Pharm. 2010 Apr 1;67(7):562-5. doi: 10.2146/ajhp090342.

DOI:10.2146/ajhp090342
PMID:20237384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3096563/
Abstract

PURPOSE

The physical compatibility of magnesium sulfate and sodium bicarbonate in a pharmacy-compounded hemofiltration solution was assessed.

METHODS

Two bicarbonate-buffered hemofiltration solutions (low- and high-magnesium formulations) were compounded in triplicate. The concentrations of magnesium (15 meq/L) and sodium bicarbonate (50 meq/L) in the high-magnesium formulation were chosen to be somewhat below the concentrations reported as being incompatible in a popular reference. The six hemofiltration bags were stored at 22-25 degrees C without protection from light for 48 hours. Physical compatibility was assessed by visual inspection and microscopy. The pH of the solutions was assayed 3-4 and 52-53 hours after compounding. Electrolyte and glucose concentrations of the solutions were assayed at 3-4 and 50-51 hours after preparation.

RESULTS

No particulate matter was observed by visual or microscopic inspection in the compounded hemofiltration solutions at 48 hours. The mean +/- S.D. pH values of the low-magnesium solutions were 8.01 +/- 0.02 and 8.04 +/- 0.02 at 3-4 and 52-53 hours after compounding, respectively. The mean +/- S.D. pH values of the high-magnesium solutions were 7.96 +/- 0.02 and 7.98 +/- 0.01 at 3-4 and 52-53 hours after compounding, respectively. The electrolyte and glucose concentrations in the low- and high-magnesium solutions were similar 3-4 and 50-51 hours after preparation.

CONCLUSION

Magnesium sulfate 1.5 meq/L and sodium bicarbonate 50 meq/L were physically compatible in a pharmacy-compounded hemofiltration solution for 48 hours when stored at 22-25 degrees C without protection from light.

摘要

目的

评估在药房配制的血液滤过溶液中硫酸镁和碳酸氢钠的物理相容性。

方法

重复配制了两种碳酸氢盐缓冲血液滤过溶液(低镁和高镁配方)。高镁配方中选择的镁(15 meq/L)和碳酸氢钠(50 meq/L)浓度略低于在一个流行参考中报告的不相容浓度。在没有避光保护的情况下,将六个血液滤过袋储存在 22-25°C 下 48 小时。通过目视检查和显微镜检查评估物理相容性。在配制后 3-4 小时和 52-53 小时测定溶液的 pH 值。在配制后 3-4 小时和 50-51 小时测定溶液的电解质和葡萄糖浓度。

结果

在 48 小时时,通过目视或显微镜检查,在配制的血液滤过溶液中未观察到颗粒物质。低镁溶液的平均 +/- S.D. pH 值分别为 8.01 +/- 0.02 和 8.04 +/- 0.02,在配制后 3-4 小时和 52-53 小时。高镁溶液的平均 +/- S.D. pH 值分别为 7.96 +/- 0.02 和 7.98 +/- 0.01,在配制后 3-4 小时和 52-53 小时。低镁和高镁溶液中的电解质和葡萄糖浓度在配制后 3-4 小时和 50-51 小时相似。

结论

在 22-25°C 下储存且没有避光保护的情况下,药房配制的血液滤过溶液中硫酸镁 1.5 meq/L 和碳酸氢钠 50 meq/L 在 48 小时内物理相容。